Intuitive Surgical, Inc. Unrealized Gain (Loss) on Investments
Intuitive Surgical, Inc. (ISRG) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-02-03
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for the quarter ending 2024-06-30 was $5.50M, a 93.67% decline year-over-year.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for the quarter ending 2024-03-31 was -$33.90M.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for the quarter ending 2023-12-31 was $29.70M.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for the quarter ending 2023-09-30 was $0.00.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for fiscal 2025 was $0.00.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for fiscal 2024 was $0.00.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for fiscal 2023 was $0.00.
- Intuitive Surgical, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$154.20M.
| Period end | Unrealized Gain (Loss) on Investments 1 month | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 6 month as first filed | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 9 month as first filed | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-03 | |||||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-03 | |||||||
| 2024-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | -$28.40M 10-Q · filed 2024-07-19 | $1.30M derived: sum of 3 quarters · filed 2025-01-31 | $1.30M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2024-03-31 | -$33.90M 10-Q · filed 2024-04-19 | -$4.20M derived: sum of 2 quarters · filed 2025-01-31 | -$4.20M derived: sum of 3 quarters · filed 2025-01-31 | $82.70M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-12-31 | $29.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $29.70M derived: sum of 2 quarters · filed 2025-01-31 | $116.60M derived: sum of 3 quarters · filed 2025-01-31 | $0.00 10-K · filed 2025-01-31 | -$29.70M 10-K · filed 2024-01-31 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-19 | $86.90M derived: sum of 2 quarters · filed 2024-07-19 | -$29.70M 10-Q · filed 2024-07-19 | -$77.90M 10-Q · filed 2023-10-20 | ||||
| 2023-06-30 | $86.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-19 | -$29.70M 10-Q · filed 2024-04-19 | -$103.50M 10-Q · filed 2023-07-24 | |||||
| 2023-03-31 | -$116.60M 10-Q · filed 2023-04-20 | |||||||
| 2022-12-31 | -$154.20M 10-K · filed 2024-01-31 | |||||||
| 2021-12-31 | -$37.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$16.00M 10-K · filed 2023-02-10 | $16.00M 10-K · filed 2022-02-03 | |||||
| 2021-09-30 | $12.30M 10-Q · filed 2021-10-20 | $21.90M 10-Q · filed 2021-10-20 | ||||||
| 2020-12-31 | $29.50M 10-K · filed 2022-02-03 | |||||||
| 2019-12-31 | $20.40M 10-K · filed 2021-02-10 | |||||||
| 2018-12-31 | -$9.80M 10-K · filed 2020-02-07 | |||||||
| 2011-03-31 | -$300.00K 10-Q · filed 2011-04-20 | |||||||
| 2010-12-31 | $1.30M 10-Q · filed 2011-04-20 | |||||||
| 2009-12-31 | $900.00K 10-K · filed 2011-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |